Global Health Press

Category - Latest Science

Literature update ViVa week 38-2026

1. Three doses help—but immunosuppressed patients remain a COVID-19 high-risk group Summary: In a systematic review and random-effects meta-analysis, Stadler and colleagues searched PubMed, Scopus, and Embase through...

Literature update ViVa week 36-2026

1. Firearms remain America’s defining youth mortality crisis Summary: In this correspondence responding to a 2026 research letter, Bleyer, Liu, and Thomas analyzed 2024 CDC WONDER mortality data for U.S. residents aged...

Literature update ViVa week 35-2026

1. GBS vaccine candidate clears a first key hurdle in HIV-endemic Africa A Ugandan phase 2 trial shows a hexavalent GBS6 vaccine candidate is safe and equally immunogenic in pregnant women with and without HIV, offering...